SEC Form 4 · accession 0001209191-18-009636
SCYNEXIS INC · SCYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gonzalez David Angulo
Officer — Chief Medical Officer
Period of report
Feb 9, 2018
Accepted (ET)
Feb 13, 2018 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.69 | Feb 9, 2018 | A | 200,000 | A | — | Feb 8, 2028 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F11/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.